(Q40424278)

English

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients (English)

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dominique Costagliola

11

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Anne-Geneviève Marcelin

1

object named as

Anne-Geneviève Marcelin

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Christine Katlama

10

object named as

Christine Katlama

0 references

Gilles Peytavin

3

object named as

Gilles Peytavin

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Constance Delaugerre

6

object named as

Constance Delaugerre

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

7

object named as

Marc Wirden

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

5

object named as

Rachid Agher

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

4

object named as

Claire Lamotte

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

2

object named as

Cécile Dalban

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

author name string

Françoise Conan

8

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Sylvie Dantin

9

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Vincent Calvez

12

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

48

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

12

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

4687-4692

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Saquinavir: a review of its use in boosted regimens for treating HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

22 September 2017

Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

22 September 2017

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

22 September 2017

Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

22 September 2017

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

25 September 2017

Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

17 June 2018

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

17 June 2018

Resistance of HIV Type 1 to Proteinase Inhibitor Ro 31-8959

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

17 June 2018

A bootstrap resampling procedure for model building: Application to the cox regression model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

17 June 2018

Clinically relevant interpretation of genotype for resistance to abacavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

20 August 2018

Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

20 August 2018

Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

20 August 2018

Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

20 August 2018

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

20 August 2018

Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529185

20 August 2018

Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of response to treatment and HIV genotypic changes during phase III trials with saquinavir and reverse transcriptase inhibitor combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.48.12.4687-4692.2004

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40424278&oldid=1897360441"